Advertisment
 

Join the Topix community today: 

Sign Up

 | 

Sign In

updated: Fri Jul 18, 2008 04:19 pm

GlaxoSmithKline News

News on GlaxoSmithKline continually updated from thousands of sources around the net.

Friday | Business Standard

Pfizer, Novartis, GSK also under USFDA scanner

Amid reports of a US Congress probe against India's largest drug maker Ranbaxy Laboratories, data show that many leading multinational companies such as Pfizer, GlaxoSmithKline, Novartis and Merck are also ...

Comment?

Related Topix: Biotech, Scanners, Food and Drug Administration

Thu Jul 17, 2008

Fool.com

Genentech Needs More Profit Power

Genentech reported yesterday that its first-quarter overall revenue rose nearly 8%. Its top drugs, including cancer treatments Avastin and Rituxan, posted blowout double-digit sales growth.

Comment?

Related Topix: Biotech, Healthcare Law, Law, Medicine, Health, Breast Cancer, Cancer, Healthcare Industry, Pfizer

Wed Jul 16, 2008

MediLexicon

Theravance Announces Positive Phase 2 Clinical Results In The MABA...

Main Category: Respiratory / Asthma Also Included In: Clinical Trials / Drug Trials Article Date: 15 Jul 2008 Theravance, Inc.

1 comment

Related Topix: Biotech, Medicine, Healthcare Industry, The College of Wooster, The University of Findlay, Theravance

Tue Jul 15, 2008

The New Zealand Herald

Glaxo takes $3b insomnia pill

British pharmaceutical giant GlaxoSmithKline is to pay up to 1.2 billion for the rights to develop and sell almorexant, an anti-insomnia treatment in its final testing.

Comment?

Related Topix: Biotech, Medicine, Insomnia, Health

Telegraph.co.uk

GSK to pay 1.6bn for insomnia drug

The UK's largest drug company, GlaxoSmithKline, is to pay up to SFr3.3bn in licensing and development fees for insomnia treatment Almorexant.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Insomnia, Health

Mon Jul 14, 2008

Reuters UK

GSK in insomnia drug deal with Actelion

Europe's biggest drugmaker GlaxoSmithKline could pay up to 3.3 billion Swiss francs for a licensing deal on a promising insomnia drug from Swiss company Actelion .

Comment?

Related Topix: Biotech, Medicine, Insomnia, Health

Sat Jul 12, 2008

Fool.com

Pfizer Looking at a Level Playing Field

It was a good play. When Pfizer 's epilepsy drug Lyrica was included in a list of 11 drugs that might need a black-box warning, company executives said it wasn't so.

Comment?

Related Topix: Biotech, Medicine, Cephalon, Healthcare Industry, Epilepsy, Health, Healthcare Law, Law

Fri Jul 11, 2008

MediLexicon

GlaxoSmithKline Responds To FDA On Cervarix And Plans To Submit Final Study Data For Approval

Main Category: Cervical Cancer / HPV Vaccine Also Included In: Pharma Industry / Biotech Industry Clinical Trials / Drug Trials GlaxoSmithKline provided the following update regarding its application to the ...

Comment?

Related Topix: Food and Drug Administration, Cervical Cancer, Health, Biotech

Wed Jul 09, 2008

Paddock Talk

Tums Announces Nationwide Search For Grand Marshal At Tums Quikpak 500

TUMS, one of the most trusted brands for indigestion and heartburn relief, is launching a nationwide search for one lucky fan to serve as the Grand Marshal of the TUMS QuikPak 500 Sprint Cup Series race at ...

Comment?

Related Topix: Medicine, Indigestion, Health, Heartburn, Martinsville, VA, Biotech, Calcium Carbonate (generic), Medication

BioSpace

GlaxoSmithKline to Double China R&D Staff

July 8, 2008 -- GlaxoSmithKline Plc said it will increase its China-based research and development staff to 350 people in the next few years.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Tue Jul 08, 2008

PR-inside.com

GlaxoSmithKline plc - PharmaVitae Profile - New Research Report on Companies and Markets

The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Mon Jul 07, 2008

MediLexicon

Adolor Provides Update On Entereg (alvimopan) Obd Program - Fda Lifts Clinical Hold On Obd Ind

Main Category: GastroIntestinal / Gastroenterology Also Included In: Clinical Trials / Drug Trials Adolor Corporation today issued an update on the Entereg Program for chronic opioid bowel dysfunction , under ...

Comment?

Related Topix: Biotech, Healthcare Law, Food and Drug Administration, Law, Adolor, Medicine, Healthcare Industry

Sun Jul 06, 2008

News Observer

GSK, Novartis plan to appeal verdict

Two large pharmaceutical companies said Thursday they will appeal a jury verdict ordering them to pay more than $114 million for overcharging the state's Medicaid program for prescription drugs.

Comment?

Related Topix: Biotech, Medicaid, Health

Sat Jul 05, 2008

MediLexicon

GSK Does Not Expect FDA Approval Of HPV Vaccine Cervarix Until End Of 2009

Main Category: Cervical Cancer / HPV Vaccine Also Included In: Regulatory Affairs / Drug Approvals Article Date: 03 Jul 2008 GlaxoSmithKline on Monday said it does not expect to receive FDA approval for its ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Cervical Cancer, Health, Food and Drug Administration

Fri Jul 04, 2008

GuruFocus.com

GlaxoSmithKline plc (GSK): Bill Nygren Initiates Holdings in GSK

GuruFocus Home >> Stock Ideas >> Recent Picks >> Glaxosmithkline Plc GSK - GlaxoSmithKline plc $117.2 Bil 18.69% 52.22% 6.3 33.19% 2.58 23.01% 4.94% $0 2664.26 Mil GlaxoSmithKline is one of the world's leading ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

WLOX

2 firms to appeal $114M verdict in drug case

Drug companies GlaxoSmithKline and Novartis say they will appeal a jury verdict ordering them to pay more than $114 million to Alavbama for overcharging the state's Medicaid program for prescription drugs.

Comment?

Related Topix: Biotech, Healthcare Law, Law, Medicaid, Health

Thu Jul 03, 2008

Medical News Today

Long-Term Study Of Middle-Aged Mice Shows Resveratrol...

Main Category: Diabetes Also Included In: Cardiovascular / Cardiology Article Date: 03 Jul 2008 - 13:00 PDT Sirtris, a GlaxoSmithKline company focused on discovering and developing small molecule drugs to treat ...

Comment?

Related Topix: Biotech, Medicine, Cataract, Health

Medical News Today

GlaxoSmithKline, Novartis Found Guilty Of Overcharging Alabama Medicaid Program, Must Pay State $114M

Main Category: Medicare / Medicaid / SCHIP Also Included In: Pharma Industry / Biotech Industry ; Medical Malpractice / Litigation Article Date: 03 Jul 2008 - 6:00 PDT An Alabama state court jury on Tuesday ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Healthcare Law, Law, Health

Med Ad News

Adolor Provides Update on Entereg (alvimopan) OBD Program

Jul 3, 2008 - Adolor Corporation today issued an update on the Entereg Program for chronic opioid bowel dysfunction , under development in collaboration with GlaxoSmithKline .

Comment?

Related Topix: Biotech, Healthcare Law, Food and Drug Administration, Law, Adolor, Medicine, Healthcare Industry

Wed Jul 02, 2008

The Washington Post

FDA panel urges more testing for diabetes drugs

By MATTHEW PERRONE The Associated Press Wednesday, July 2, 2008; 4:31 PM WASHINGTON -- Diabetes drugs would be subject to more stringent safety standards that could cost manufacturers millions, under ...

Comment?

Related Topix: Food and Drug Administration, Diabetes, Health, Biotech, Healthcare Industry

↑ Back to top

More GlaxoSmithKline News

Archives

Read more articles in the GlaxoSmithKline News Archives.

For up to the minute news, check out the GlaxoSmithKline News Wire.

Want to add GlaxoSmithKline News headlines to your web site? Get the widget here.

GlaxoSmithKline News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make GlaxoSmithKline News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

GlaxoSmithKline Photos

Topix Quick Poll

created by: Topix Pollster | Jan 7, 2008

Click on an option to vote

3,487

votes

  • Help
  • Hurt
  • I don't know
  • Other (comment)

Los Angeles Jobs